Type 2 diabetes and its genetic susceptibility are associated with increased severity and mortality of COVID-19 in UK Biobank

作者：A. Lee, Ji-Eun Seo, Seunghwan Park, Youngkwang Cho, Gaeun Kim, Jun Li, Liming Liang, Taesung Park, Wonil Chung · 发表于：Communications Biology · 年份：2024 · DOI：10.1038/s42003-024-05799-1 · 被引用次数：9 · 研究领域：COVID-19 Clinical Research Studies、Diabetes and associated disorders、SARS-CoV-2 and COVID-19 Research

Type 2 diabetes (T2D) is known as one of the important risk factors for the severity and mortality of COVID-19. Here, we evaluate the impact of T2D and its genetic susceptibility on the severity and mortality of COVID-19, using 459,119 individuals in UK Biobank. Utilizing the polygenic risk scores (PRS) for T2D, we identified a significant association between T2D or T2D PRS, and COVID-19 severity. We further discovered the efficacy of vaccination and the pivotal role of T2D-related genetics in the pathogenesis of severe COVID-19. Moreover, we found that individuals with T2D or those in the high T2D PRS group had a significantly increased mortality rate. We also observed that the mortality rate for SARS-CoV-2-infected patients was approximately 2 to 7 times higher than for those not infected, depending on the time of infection. These findings emphasize the potential of T2D PRS in estimating the severity and mortality of COVID-19.